Clinical Trial: Evaluating Preventive Therapy With Oint Threolone, Synthomycine or Aqua Cream, for EGFR'I Induced Acneiform Rash
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Double Blind Placebo Controlled Trial, for Evaluating Preventive Therapy With Either Oint Threolone Versus Synthomycine Versus Aqua Cream, for EGFR'I Induced Acneiform Rash
Brief Summary: The investigators hypothesized that topical anti-inflammatory treatment could counteract the inflammatory reaction induced by EGFR'Is.
Detailed Summary: The investigators hypothesized that topical anti-inflammatory treatment could counteract the inflammatory reaction induced by EGFR'Is.
Sponsor: Rabin Medical Center
Current Primary Outcome: Number of patients developing grade 2 / above rash under preventative treatment with ointment threolone, compared to the other 2 treatment arms. [ Time Frame: 3 years ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Number of patients developing a rash under preventative treatment with ointment threolone, compared to the other 2 treatment arms [ Time Frame: 3 years ]
Original Secondary Outcome: Same as current
Information By: Rabin Medical Center
Dates:
Date Received: December 7, 2010
Date Started: January 2011
Date Completion:
Last Updated: May 7, 2017
Last Verified: May 2017